Fra-1 expression in malignant and benign thyroid tumor

scientific article published on June 2001

Fra-1 expression in malignant and benign thyroid tumor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3904/KJIM.2001.16.2.93
P932PMC publication ID4531708
P698PubMed publication ID11590908
P5875ResearchGate publication ID11758823

P2093author name stringY H Kim
S J Kim
K M Choi
D S Choi
N H Kim
S H Baik
J H Oh
E S Lee
P2860cites workNeoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene productQ28567617
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformationQ29400446
AP-1 function and regulationQ29618422
Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single geneQ33846819
Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancersQ34209006
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cellsQ34987802
Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasiaQ35596740
Cellular transformation and malignancy induced by ras require c-junQ36561672
Analysis of AP-1 function in cellular transformation pathwaysQ38307542
Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice.Q38312652
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cellsQ40015832
Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intronQ40016658
Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalizationQ40018661
RETRACTED: A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation patternQ40124496
Cancer in thyroid nodules. A community hospital surveyQ40238670
Cooperation between the polyomavirus middle-T-antigen gene and the human c-myc oncogene in a rat thyroid epithelial differentiated cell line: model of in vitro progressionQ40649900
Molecular basis of thyroid cancerQ40669075
One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenesQ40671275
Regulation of the transcription factor AP-1 in benign and malignant mouse keratinocyte cellsQ41141891
Okadaic acid stimulated TRE binding activity in a papilloma producing mouse keratinocyte cell line involves increased AP-1 expression.Q41192829
Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cellsQ41437069
The Adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes.Q41575842
Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domainsQ41632670
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.Q42801463
Transformation by ras modifies AP1 composition and activityQ42803630
The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancyQ44578914
Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivoQ47741367
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.Q52501771
Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.Q53457045
c-fos is required for malignant progression of skin tumors.Q53461261
P433issue2
P304page(s)93-97
P577publication date2001-06-01
P1433published inThe Korean journal of internal medicineQ26842387
P1476titleFra-1 expression in malignant and benign thyroid tumor
P478volume16